I remember chatting with you on the Cryoport board, where it was taboo to admit we were invested in NWBO. Times have changed since those days. I remember buying Cyrx for 15 cents. I also bought into an offering for 2 dollars a share with great terms. Sold that way too early at 30, on it's way to 85. Hope I have the same luck here. I am a class 4 investor.... Goodluck to you, always appreciate your well researched insights.
hyperopia, I don't have PM so I cannot reach out to you outside of a public comment here. I appreciate your technical related process posts. I am now retired and wonder if we ever crossed paths in the industry? Some day maybe we will meet at Sawston or at an ASM? Thanks for your posts and please continue to share your experienced perspectives.
Validation should not be a horrible experience if properly done after sound development. If validation is extended it is typically not a good reflection on the development work. It is possible a problem with an assay turned up or any other nuanced result but this process validation should be very manageable if the device development work and process development work were well done.
News 
Market Data 
Discover 
AI
